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ABSTRACT
Instrumented multilevel spine surgery is associated with a large amount of opioid
consumption, difficult mobilization, and significant pain in a population of patients who
are predominantly already chronic pain sufferers (Mathiesen et al., 2013). The Health
Resources and Services Administration (2018) recently claimed that our nation is in the
midst of an opioid epidemic, with more than 115 opioid-related deaths occurring every
year. As a result of this epidemic, many anesthesia providers have become aware and are
attempting to do something about it. Organizations such as the Society for Opioid Free
Anesthesia are at the forefront of the battle against the opioid crisis, promoting alternative
drug therapy for pain control during and following surgery. This response has been an
effort to not only prevent chronic pain but ultimately, to limit our population’s worsening
dependence on opioids. One of the most common alternatives to opioids being used is
dexmedetomidine. This project, inspired by the current crisis, involved the creation of a
policy that details the use of intraoperative dexmedetomidine on patients undergoing
instrumented spinal surgery. Collaboration with a physician anesthesiologist and an
evidence review guided the development of the policy. Following completion, the policy
was present to a panel of experts, which consisted of anesthesia providers who routinely
take part in spinal surgery cases. Feedback was taken from the panel using a survey tool.
Results of the survey revealed that the experts were willing to consider changing their
practices to include dexmedetomidine as part of their anesthetic care.
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CHAPTER I - INTRODUCTION
From 1999 to 2014, prescription opioid sales nearly quadrupled in the United
States. In the same period, no overall change in reported pain was reported (Centers for
Disease Control and Prevention [CDC], 2017). The number of opioid overdose deaths has
increased at a similar rate as the number of opioid prescriptions (CDC, 2017). It is
estimated that 1 in 5 patients with pain-related and non-cancer diagnoses is prescribed
opioids (CDC, 2017). The number of prescriptions has increased the most among
specialists, with surgery prescribing rates among the highest at 37% (CDC, 2017).
Greater than 115 Americans die every day from an opioid overdose, with nearly half of
those deaths involving a prescription opioid (Mississippi State Department of Health
[MSDH], 2018). The highest ratio of prescriptions per person in the country is found in
the southern states, including Mississippi where opioid involved overdose deaths have
doubled since the year 2000 (MSDH, 2018). Patients undergoing spinal surgery are likely
receiving prescriptions for opioids prior to having the procedure. In addition, pain is a
common and an expected outcome in patients undergoing these procedures due to the
unavoidable tissue damage that occurs during instrumented spinal surgery (Devin &
McGirt, 2015). Opioids are commonly continued postoperatively following spinal
surgery, typically, the first-line agent in post-operative pain management (Devin &
McGirt, 2015). The overuse of opioids has been “associated with significant adverse side
effects including somnolence, confusion, urinary retention, ileus, respiratory depression,
and death” (Devin & McGirt, 2015, p. 931). Post-operative pain manifests through
multiple neurophysiological and chemical pathways. Additionally, sensitization
peripherally and centrally further contributes to the occurrence of hyperalgesia, which
1

results in increased pain. Due to this, multimodal approaches to pain management have
become prevalent among anesthesia providers, targeting multiple pain signaling pathways
to improve pain management, while minimizing adverse effects (Devin & McGirt, 2015).
Due to the alarming increase in opioid prescriptions and overdoses involving opioids, it is
important that anesthesia providers be aware of the epidemic and up to date on the most
recent recommendations for multimodal pain management.
Background and Significance
Instrumented multilevel spine surgery is associated with a large amount of opioid
consumption, difficult mobilization, and significant pain in a population of patients who
are predominantly already chronic pain sufferers (Mathiesen et al., 2013). Over the last
10 years, the number of patients having spinal surgery has seen an increase (Mathiesen et
al., 2013). Spinal procedures are associated with intense postoperative pain, especially in
the immediate days following surgery. A considerable degree of pain is common due to
the extensive dissection of tissues, ligaments, and bones. The pain resulting from these
surgeries is typically severe and lasts for approximately three days. Complicating the
postoperative pain management picture is the fact that most of these patients are already
being treated with traditional narcotics or analgesics preoperatively. Postoperative pain
results from activation of varying mechanisms, including neuropathic, nociceptive, and
inflammatory pathways (Mathiesen et al., 2013). A balanced approach to postoperative
pain management that targets multiple pain pathways is a logical course of action
(Mathiesen et al., 2013). Dexmedetomidine is a highly selective alpha 2 adrenoceptor
agonist, with analgesic and sedative properties, that is being increasingly used as an
adjunct to multimodal pain management strategies (Ramsay & Luterman, 2004).
2

Problem Statement
The use of opioids is an essential element of pain management perioperatively,
however, their detrimental side effects are well known and feared among anesthesia
providers. The escalating use of prescription opioids over the last 20 years has caused
their clinical utilization to become a public health concern. Many practitioners and
policymakers have called for a reduction in the number of prescriptions as they aim to
reconcile the commitment to deliver effective control of pain, with the circumvention of
opioid-related side effects. Trending increases in spinal surgical volume will more than
likely potentiate the problem. The emergence of dexmedetomidine as an effective agent
for providing analgesia post spinal surgery has given anesthesia providers another adjunct
to use for multimodal pain management. The decision to use opioid alternatives, such as
dexmedetomidine, is solely in the hands of the individual provider. The development of
an intraoperative dexmedetomidine policy may help create a standard, increase its
utilization, decrease postoperative pain, and prevent further contribution to the current
opioid epidemic (Cozowicz et al., 2017).
Purpose of the Project
The purpose of this project was to construct a policy for the use of
dexmedetomidine intraoperatively in spinal surgery in an effort to reduce postoperative
pain and opioid usage. The policy was written for an orthopedic specialty hospital in
southeast Mississippi and was designed to be a point of reference for the providers who
practice there. Specific instructions were included related to appropriate dosage, timing
of administration, and patient exclusion criteria founded on the most recent evidencebased research and best practice recommendations. The goal of the policy was to educate
3

the providers and present guidelines that would allow for the safe and effective
administration of dexmedetomidine, as a supplement to multimodal pain management.
Needs Assessment
In order to determine the providers’ knowledge base and competency concerning
proper dexmedetomidine administration during spinal surgery, a needs assessment was
performed. Many providers feel that the time it takes to prepare the infusion makes it an
unfeasible option, while others were unaware of the analgesic properties of
dexmedetomidine. Many providers do not have a firm understanding of the most
effective dosage and timing of administration, while others do not have adequate
knowledge regarding patient inclusion and exclusion criteria. Having a policy
implemented will allow for guidance, instruction, and education that will lead to an
increase in the use and effectiveness of dexmedetomidine. The policy is being written at
the request of the medical director at the Orthopedic Institute (OI), a specialty orthopedic
surgery center in Hattiesburg, MS.
Conceptual Framework
The conceptual framework used for this project was Friedman’s Policy
Development Framework. Friedman (2003) presented a framework for the development
of policy and implementation, based on a review of the evidence. The framework focuses
on four dimensions:
1. The stages of policy development and implementation
2. The levels at which policy is developed and the interrelationships among the
levels
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3. The service sectors or systems affected by policy and the interrelationships
among policy in different sectors
4. The variables that are likely to affect the level of impact of a policy
(Friedman, 2003, p. 12)
The Stages of Policy Development and Implementation
Five stages can be identified in policy development and implementation.
Identification of a problem needing to be addressed is the first stage. The second stage,
policy development, follows the problem identification. After the new policy is
established, the third stage is the implementation of the statute. Evaluation of the impact
of the policy and the effect of its implementation is the fourth stage. Finally, the fifth
stage is a modification of the policy with or without modification of the implementation
approach (Friedman, 2003).
The Levels at Which Policy is Developed and the Interrelationships among the Levels
Policies are often established at different levels. The most crucial aspect,
however, may not be the specific level that establishes the policy, but the relationships
between the different levels in the implementation. The relationships play a vital role in
the final impact of the policy (Friedman, 2003).
The Service Sectors or Systems Affected by Policy and the Interrelationships among
Policy in Different Sectors
The previous dimension deals with groups on different levels, or vertical issues.
An example of a vertical issue is the relationship between hospital administration and a
hired anesthesia group. This dimension applies to more horizontal relationships or entities
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on the same level. Such relationships would include those between a hospital’s pharmacy
and the operating room (Friedman, 2003).
The Variables That Are Likely to Affect the Level of Impact of a Policy
This dimension deals with describing variables that are thought to be related to
the policy’s success in achieving its goals. A policy’s effectiveness in achieving its
intended outcome is dependent on three different variable types: “(a) those related to the
nature of the problem that the policy addresses; (b) those related to the policy itself and
its implementation; and (c) those that although not related to the policy, affect its
implementation nonetheless” (Friedman, 2003, p. 13). Positive results will more likely
occur in situations where a clear understanding of the necessary changes to solve the
problem is present, the desired behavior to be regulated is unvaried, the problem does not
involve a large subset of people, and the amount of change required is minimal
(Friedman, 2003).
DNP Essentials
The American Association of the Colleges of Nursing (AACN, 2006) have
provided eight essential components required for completion of a Doctorate of Nursing
Practice (DNP). These eight essentials are foundational competencies and are a
requirement of all DNP graduates in all specialties. This project has addressed each
essential and is outlined below.
DNP Essential I: Scientific Underpinnings for Practice
Knowledge of the sciences was used to translate research findings into a policy
for the use of dexmedetomidine intraoperatively. This policy was an example of
development and evaluation of new practice approaches that were theory based in
6

nursing. The significance, as well as the nature of the problem, was determined. Actions
and advanced strategies to enhance the use of dexmedetomidine was described in the
policy and outcomes were evaluated (AACN, 2006).
DNP Essential II: Organizational and Systems Leadership for Quality Improvement and
Systems Thinking
The organizational and systems leadership requirement was met by improving the
safety of patients receiving dexmedetomidine intraoperatively, through the use of policy
writing. The need for a multimodal approach to pain management in the population of
patients undergoing spinal surgery was assessed based on scientific, organizational,
political, and economic sciences. The policy, in a sense, was a method of communication
that could potentially lead to an improvement in quality and patient safety within the
facility for which it is developed (AACN, 2006).
DNP Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based
Practice
Prior to the development of the policy, analytical methods were used to critically
appraise the existing evidence, to determine the best evidence for practice. Information
technology was utilized, and research methods applied to collect the appropriate data to
formulate the policy. Data were analyzed, and patterns of outcomes and behavior were
examined to identify gaps in the evidence and construct the policy (AACN, 2006).
DNP Essential IV: Information Systems/Technology and Patient Care Technology for the
Improvement and Transformation of Health Care
The policy development and intervention for this project were created using
information systems/technology. The policy was designed to support the healthcare
7

system it was developed for and improve patient care. Technical skills and conceptual
ability was demonstrated to develop the evaluation plan following policy development
(AACN, 2006).
DNP Essential V: Health Care Policy for Advocacy in Health Care
The fifth essential was met through institutional decision making if they chose to
accept the policy. Organizational standards created a framework to facilitate the delivery
of dexmedetomidine. “The engagement in the process of policy development is central to
creating a healthcare system that meets the needs of its constituents” (AACN, 2006, p.
13). The policy was designed to influence, regulate the practice, improve safety, enhance
quality, and ameliorate the efficacy of providers (AACN, 2006).
DNP Essential VI: Interprofessional Collaboration for Improving Patient and Population
Health Outcomes
The development of the policy was executed through collaboration with the
physician anesthesiologist and medical director of the facility, the facility’s stakeholders,
as well as nurse anesthesia program faculty from The University of Southern Mississippi
(USM). Interprofessional collaboration was employed to improve health outcomes. The
development of the policy using collaboration fulfilled the requirement of essential seven
(AACN, 2006).
DNP Essential VII: Clinical Prevention and Population Health for Improving the
Nation’s Health
One of the goals of developing the dexmedetomidine policy was a reduction in
the requirement of opioids intraoperatively and, secondarily, a reduction in the number of
patients being discharged home with opioid prescriptions. This implementation can be a
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small step in the right direction of resolving our nation’s opioid crisis. The more policies
developed that have the potential to reduce narcotic consumption, the faster the trending
rise in usage can be reversed (AACN, 2006).
DNP Essential VIII: Advanced Nursing Practice
The eighth and final essential was met through the design, implementation, and
evaluation of the policy as an intervention based on nursing sciences. The policy
demonstrated an advanced level of clinical judgment, accountability in design, delivery,
and systems thinking. Evaluation of evidence-based treatments and dexmedetomidine
research was utilized to improve patient outcomes (AACN, 2006).
Review of Evidence
An extensive literature review was performed to examine all current evidence of
dexmedetomidine’s use as an analgesic agent. Databases used included CINAHL with
Full-Text, PubMed, MEDLINE, Google Scholar, and Cochrane Library. Terms used in
the search included: dexmedetomidine, dexmedetomidine spine surgery, spine surgery,
perioperative pain, dexmedetomidine pain, multimodal analgesia, opioid sparing,
postoperative pain, opioid spine surgery, and policy. Filtering criteria limited searches to
full text only with publication dates between 2008 and 2018, which resulted in 105 fulltext articles after accounting for duplications. After reviewing all articles, 19 were chosen
for the inclusion of the project due to their applicability to the topic.
Multimodal Pain Management for Spinal Surgery
Surgical procedures on the spine are typically associated with severe pain in the
postoperative period, especially in the first few days (Bajwa & Haldar, 2015). Pain
management after spine surgery has historically relied on the heavy usage of opioid
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medications (Kurd, Kreitz, Schroeder, & Vaccaro, 2017). Multimodal strategies of pain
control were designed to minimize opioid consumption and the adverse effects associated
with their use (Kurd et al., 2017). A growing amount of evidence supports the use of a
multimodal technique to pain management during spine surgery (Kurd et al., 2017).
Providing patients with adequate postoperative pain control enables for faster
rehabilitation, improved mobility, and improved patient satisfaction scores (Kurd et al.,
2017). Adequate postoperative pain management has also been shown to prevent the
development of chronic pain (Bajwa & Haldar, 2015). Alpha 2 agonists, such as
clonidine and dexmedetomidine have proven to be effective agents to provide analgesia
in spinal surgery (Bajwa & Haldar, 2015). The lack of respiratory depression and their
hemodynamic stability are added benefits of these drugs (Bajwa & Haldar, 2015). Bidyut
and Amutha (2012) found dexmedetomidine to be an ideal anesthetic adjuvant in patients
undergoing cervical spine surgery. In these patients, dexmedetomidine provided
decreases in anesthetic requirements, a reduction in intubation response, improvements in
analgesia, and avoided significant respiratory and hemodynamic compromise (Bidyut &
Amutha, 2012).
Sparing Effect of Dexmedetomidine and Recovery
“Dexmedetomidine presumably acts on the nociceptive cascade and prevents the
sensitization of nociceptors present in the dorsal horn” (Bajwa & Haldar, 2015, p. 109).
Dexmedetomidine has a high affinity and selectivity and aids in the decrease of opioid
and local anesthetic dosages, therefore, reducing the risk of the adverse effects of these
medications when they are used simultaneously with dexmedetomidine (Bajwa & Haldar,
2015). Intraoperative dexmedetomidine has been shown to reduce anesthetic
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requirements and lead to early tracheal extubation postoperatively (Afanador et al.,
2009). Dexmedetomidine is capable of attenuating various stress responses and is able to
maintain hemodynamic stability during surgery when used as an adjuvant during general
anesthesia (Patel, Engineer, Shah, & Madhu, 2012). Additionally, dexmedetomidine
administered intraoperatively appears to enhance the analgesic property of morphinebased patient-controlled analgesia (PCA) in spinal surgery patients postoperatively (Ge,
Qi, Tang, & Li, 2015).
Reduction of Postoperative Side Effects
In addition to providing improvements in analgesia and reductions in narcotic
requirements, dexmedetomidine has been shown to limit postoperative side effects of
anesthesia (Bakri, Ismail, & Ibrahim, 2015). “Dexmedetomidine has an effect similar to
that of dexamethasone in reducing the incidence and severity of postoperative nausea and
vomiting (PONV)” (Bakri et al., 2015, p. 259). A recent meta-analysis by Wang et al.
(2016) concluded that dexmedetomidine given perioperatively decreased the incidence of
shivering and postoperative nausea in laparoscopic surgery patients. Another study by
Choi et al. (2017) found similar results, stating that “adjuvant use of intraoperative
dexmedetomidine infusion may be effective for the prevention of PONV” (p. 1).
Dexmedetomidine Dosage
The use of dexmedetomidine intraoperatively is well established to improve pain
control postoperatively, with or without a loading dose (Fan et al., 2017). In a study
comparing the use of dexmedetomidine with and without a loading dose, Fan et al. (2017)
found that the administration of a loading dose did not affect the analgesic effect. A
review conducted by Ickeringill, Shehabi, Adamson, and Reuttimann (2004) determined
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that undesirable hemodynamic effects could be avoided without compromising analgesia
by omitting a loading dose. Tiwari (2014) compared two different doses of
dexmedetomidine and their effects on postoperative pain and sedation. Patients were
divided randomly into three groups—a control group (saline infusion), a low dose
dexmedetomidine infusion group (0.3 mcg/kg/hr), and a high dose dexmedetomidine
infusion group (0.6 mcg/kg/hr) (Tiwari, 2014). The usage of fentanyl, duration of
infusion, and duration of surgery was determined to be statistically insignificant in all
three groups (Tiwari, 2014). Pain scores in both dexmedetomidine groups were
significantly lower than the control group in the period immediately after surgery through
six hours post-surgery (Tiwari, 2014). Tiwari (2014) concluded that both dosages of
dexmedetomidine provided similar improvements in postoperative pain control. The
recommended dose range of dexmedetomidine is 0.2 to 0.7 mcg/kg/hr for no longer than
24 hours (Kim, 2014).
Summary
The significant pain associated with spinal surgery and the increasing reliance on
opioids are representative of the background and significance of this project.
Development of intraoperative dexmedetomidine policies may allow for a reduction in
narcotic usage. The purpose of the project was to construct such a policy that would
outline the use of dexmedetomidine during multilevel instrumented spinal surgery. A
needs assessment was performed to determine the current knowledge base of the
anesthesia providers at the OI. The review of the evidence presented dexmedetomidine as
a useful adjunct to multimodal pain management and provided insight on optimal dosage
and timing. Dexmedetomidine was shown to have a sparing effect on narcotics, enhance
12

recovery, and reduce postoperative side effects. The theoretical framework outlined
above was chosen because it was based on evidence and focused on policy development
and implementation. Eight DNP essentials required by the AACN have been addressed
by completion of this project.
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CHAPTER II – METHODOLOGY
Population
This project targeted two populations of interest. The primary population was
patients undergoing multilevel instrumented spine surgery. A second population was the
anesthesia providers at the OI, a specialty orthopedic surgery center in Hattiesburg,
Mississippi.
Target Outcome
The expected outcome of my project was to create a policy that would provide
stakeholders at the OI a thorough evidence-based policy. A thorough evidence-based
policy would offer the opportunity for a change in the practice of the anesthesia providers
at the OI if they chose to implement it. The goal was for the policy to provide a resource
that was easily referenced when required and provide a pathway to increase the use of
dexmedetomidine during spinal surgery. Increased dexmedetomidine use can potentially
improve pain control and may lead to a decrease in postoperative pain and perioperative
opioid use.
Design
In collaboration with a physician anesthesiologist and medical director of the OI,
an evidence-based policy was developed and submitted for implementation in an effort to
increase the routine use of intraoperative dexmedetomidine infusions during spinal
surgeries. The policy contained information regarding dosage and timing of
administration, exclusion criteria for specific patient populations, and guidelines for
administration. Once completed, the policy was presented to an expert panel including
anesthesia providers, hospital administrators, DNP, and Certified Registered Nurse
14

Anesthesia (CRNA) faculty at USM. Input was received, and the survey completed. The
survey was given to the expert panel and contained questions such as: “How would you
make the policy more user-friendly?”, “What would you add to make the policy better?”,
and “What would you add or remove to make the policy clearer or more concise?” Data
from the results of the surveys were collected and analyzed. The finalized policy was
presented to the DNP project committee members and again to the panel of experts.
Lastly, recommendations and the completed policy were submitted via email in pdf
format to the medical director of the OI for his consideration to implement the policy.
Barriers
It was important to be prepared for challenges that were possible during the
project implementation. Although outside the scope of this project, one potential barrier
to the acceptance of an institutional policy was resistance to change on the part of the
members of the institution. If pushback was received from the providers of the OI,
progress may have been slowed. Consultation with a collaborating physician and director
of the OI would hopefully alleviate any hesitancy from the anesthesia staff. Other
potential barriers included the increased cost to add the drug to the formulary of the
pharmacy, as well as adequately educating the recovery nurses on the proper care of
patients receiving dexmedetomidine intraoperatively. The director of the OI agreed to
discuss and negotiate these requirements with the pharmacy as needed.
Ethical Considerations
The Institutional Review Board (IRB) at USM approved this project prior to
creation, presentation, and implementation of the policy (Protocol #18071906). No
human subjects were being studied; therefore, IRB approval from the OI was not
15

necessary. Any participation in this project was completely voluntary. At the patient
level, a few ethical situations were considered. Inequality of care was an important
ethical issue to consider in the process of developing the policy for this project. An
example of inequality of care would be if one provider used dexmedetomidine for a
patient, while another provider chose not to use the drug on another patient undergoing
the same procedure. Another consideration was the issue of an uninsured patient not
having the ability to pay for the drug or an insured patient whose insurance company
denied payment. An adequate policy would assist to prevent unethical situations from
arising in anesthetic planning and the care of patients.
Components of a Quality Policy
Policies are written to address an institution or organization’s specific need. The
components and structure of a policy will vary according to the need; some being several
pages, while others may be a single page. The organization, Sport and Recreation
Victoria, suggests that a quality policy has nine components. The first component is a
goal statement of what the organization would like to achieve. The goal for this project
was for the policy to provide a resource that was easily referenced when required and
provide a pathway to increase the use of dexmedetomidine during spinal surgery.
Improvement in pain control could lead to a decrease in postoperative pain and
perioperative opioid use. The second component is that the policy is founded on
principles, values, and philosophies. The policy for the OI was founded on evidencebased research. The third objective is that the policy should contain broad objectives that
clearly define what areas the organization is involved in. The policy clearly stated for
dexmedetomidine to be used intraoperatively, which met the objective. Objective four
16

states that there should be strategies included to achieve each objective. Specific actions
to be taken should be included in the policy, which is objective five. Objective six states
that a policy should include desired outcomes of the specific actions. When constructing
the policy, detailed instructions and strategies, along with desired outcomes were
provided to ensure objectives four, five, and six were met. The seventh objective is for
the policy to include performance indicators that the policy can be effectively measured
by. Management plans are included as the eighth objective and provide further detail on
the policy’s implementation and observation on a daily basis. Objectives seven and eight
were met through assistance from the collaborating physician and medical director, and
the stakeholders of the OI. The preference for management plans, observation, and
performance indicators would be included by the medical director, as it is ultimately his
decision whether to implement or not. Finally, the last and ninth objective is that the
policy should be reviewed yearly. Examination of performance indicators, a discussion
forum involving risk management professionals and management, and consultation of
members of the organization should all be a part of the review (Isaac, n.d.). Perhaps the
subject of a future DNP project could be the review and analysis of the policy
implementation.
Policy Writing
The foundation of any healthcare organization is patient safety. Policies guide
patient care and are designed to provide better outcomes but only if they are well written.
Many factors determine the appropriate formulation of a policy—healthcare regulations,
evidence-based practices, and accreditation standards. The key points in the following
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paragraph must be considered when writing a policy to guide healthcare providers
(Heslip, n.d.).
Policies should be written by those or with the help of those who are experts on
the topic. A one-size fits all approach to policy writing should be avoided, making sure to
review existing policies and cross-reference them as needed to prevent a policy from
contradicting with another. A policy should be original, and not simply a copy and paste
from a textbook or other literature source. The policy should be written following a
standardized format and writing style and stored in an easily accessible location. A
designated location allows those who are searching for the policy to know exactly where
they need to look for the correct information. After completion of the policy, it should be
reviewed by an expert in regulatory matters, and ideally someone with experience in
patient safety. Lastly, the policy writing should involve staff who will be following the
policy. A consultant or member of a policy and procedure committee can represent the
staff during the initial phases of policy development and implementation (Heslip, n.d.).
Summary
The goal of the project was to create an evidence-based policy as a resource for
the target population of CRNAs at the OI. The policy could potentially improve
perioperative pain in patients undergoing instrumented spinal surgery, the other
population involved in the project. The design included collaboration with the medical
director of the OI in constructing the policy while utilizing the latest research.
Throughout the course of the project, potential barriers and ethical issues were carefully
considered, as were the components of a quality policy and the keys to effective policy
writing.
18

CHAPTER III – RESULTS
Recent evidence, recommendations from the manufacturer of dexmedetomidine,
and input from the medical director of the OI were utilized in the creation of the policy
for this project. The policy was presented to a panel of experts, which included six
CRNAs who currently practice at the OI. The participants were chosen because of their
active involvement in the anesthetic care of patients undergoing spinal surgery. The
inclusion of these panel members was also influenced by the fact that they would likely
have been able to provide beneficial feedback. Information provided included recent
research related to the dosage, timing, and effects of dexmedetomidine administration.
The panel was asked to read over the presented policy and complete a 5-question survey
aimed at gaining feedback.
The results of the surveys are as follows. All participants reported that the policy
was user-friendly, clear and concise, and met the needs of the institution. In addition, all
6 participants reported that the policy would help them utilize dexmedetomidine
effectively. One participant answered “No” when questioned if they would consider
changing their current practice. Beneath the answer, the respondent indicated that they
were already utilizing dexmedetomidine intraoperatively during spinal surgery. The
presentation validated this participant’s current practice and was considered positive
feedback. The rest of the respondents answered “Yes” to the question and indicated that
they would consider changing their practice based on the information provided. No
additional comments or suggestions were presented.

19

Summary
The panel of experts agreed that the policy was clearly and concisely worded, was
user-friendly, and met the needs of their institution. The panel also unanimously believed
that the policy enabled them to utilize dexmedetomidine effectively. Those who were not
already doing so said they would consider changing their practice to include
intraoperative dexmedetomidine in the anesthetic care of patients undergoing multilevel
instrumented spinal surgery.
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CHAPTER IV – DISCUSSION
Summary
The purpose of this project was to gather evidence that supported the use of
dexmedetomidine during spinal surgery and use that evidence to develop a policy, in
hopes to implement a practice change. The trending increase in our nation’s opioid
consumption was the inspiration for this project, but the benefits of dexmedetomidine use
go far beyond a reduction in narcotic administration. The evidence presented in this
project and to the panel of experts showed that intraoperative dexmedetomidine
administration reduced the requirement of other anesthetic agents and opioid
consumption, decreased PONV and shivering, maintained hemodynamic stability,
reduced sympathetic responses to intubation, avoided significant respiratory compromise,
increased patient satisfaction scores, and led to earlier tracheal extubation and recovery
times. This evidence-based research was the foundation of the policy. The policy was
developed and written based on Friedman’s Policy Development Framework, the
recommendations on policy writing, and the components of a quality policy that were
outlined in Chapter II.
Interpretation
Based on the results of the survey, this project was successful in eliciting a
pathway to practice change. All members of the panel provided positive feedback to the
effects of dexmedetomidine and the rationale for its use in spinal surgery. In addition, all
members of the panel were satisfied with the way in which the policy was written and
worded. Due to the absence of suggestions in the surveys collected, no indications for
policy revision were present. The decision as to whether the policy was to be
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implemented or not was left up to the director of the OI. One of the potential barriers to
this project was the provider’s having a resistance to change. Any such resistance did not
exist based on the findings.
Limitations and Future Implications
The sample size of the expert panel was one limitation for this project. The OI is a
small facility with 6 operating rooms, and therefore, they do not have many CRNAs there
day in and day out. Developing a similar policy for a larger facility may have a greater
impact on the practice of anesthesia, as it would reach more providers. Still, it is possible
for a small change to kick-start a much larger movement. Perhaps a future DNP project
can be constructing a similar policy for larger/additional institutions. Another limitation
was the cost of dexmedetomidine. The added cost of adding the drug to the anesthetic
plan of all spinal surgeries would make it difficult for the OI to justify the
implementation of the policy. Another future DNP project could be based on a costanalysis of the policy’s implementation. The implementation of the policy itself could
also be considered a limitation. To remain concise and focus on proper policy creation,
the decision was made to exclude the implementation process within this project. A
prospective DNP student may choose to investigate the policy implementation process as
a topic moving forward.
Conclusions
The number of patients undergoing spinal surgery, a painful and stimulating
procedure typically associated with heavy opioid use both intraoperatively and
postoperatively, has increased over the last ten years with no signs of slowing down.
Combine the increase in spinal surgery procedures with the rampant opioid crisis
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currently affecting our country, and it poses a significant problem that will require
intervention. This situation presents a prime opportunity to make an impact, by
implementing practice change among anesthesia providers. The utilization of the various
multimodal non-narcotic agents, such as dexmedetomidine, is a great place to start in the
fight against the epidemic. This project, as well as similar ones done in the future, can
encourage an increase in these adjuncts and a decrease in opioid use. Hopefully, this
project can assist in advancing the opioid-free movement among anesthesia providers, or
at the very least, allow for a reduction in the reliance on narcotics.
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